- Home
- ORGO vs BZH Comparison
ORGO vs BZH Comparison
Compare ORGO & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- BZH
- Stock Information
- Founded
- ORGO 1985
- BZH 1985
- Country
- ORGO United States
- BZH United States
- Employees
- ORGO N/A
- BZH N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- BZH Homebuilding
- Sector
- ORGO Health Care
- BZH Consumer Discretionary
- Exchange
- ORGO Nasdaq
- BZH Nasdaq
- Market Cap
- ORGO 665.8M
- BZH 591.6M
- IPO Year
- ORGO N/A
- BZH 1994
- Fundamental
- Price
- ORGO $4.45
- BZH $18.89
- Analyst Decision
- ORGO Buy
- BZH Strong Buy
- Analyst Count
- ORGO 2
- BZH 3
- Target Price
- ORGO $5.50
- BZH $39.67
- AVG Volume (30 Days)
- ORGO 1.4M
- BZH 404.5K
- Earning Date
- ORGO 05-08-2025
- BZH 05-01-2025
- Dividend Yield
- ORGO N/A
- BZH N/A
- EPS Growth
- ORGO N/A
- BZH N/A
- EPS
- ORGO N/A
- BZH 3.93
- Revenue
- ORGO $482,043,000.00
- BZH $2,412,332,000.00
- Revenue This Year
- ORGO $3.31
- BZH $12.48
- Revenue Next Year
- ORGO $12.50
- BZH $14.99
- P/E Ratio
- ORGO N/A
- BZH $4.97
- Revenue Growth
- ORGO 11.29
- BZH 12.27
- 52 Week Low
- ORGO $2.17
- BZH $17.37
- 52 Week High
- ORGO $6.71
- BZH $38.22
- Technical
- Relative Strength Index (RSI)
- ORGO 52.57
- BZH 43.95
- Support Level
- ORGO $4.11
- BZH $17.78
- Resistance Level
- ORGO $4.38
- BZH $18.61
- Average True Range (ATR)
- ORGO 0.35
- BZH 1.30
- MACD
- ORGO 0.03
- BZH 0.09
- Stochastic Oscillator
- ORGO 80.17
- BZH 42.08
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.